TROUBLE AHEAD FOR THE NATIONAL CHLAMYDIA SCREENING PROGRAMME?

Opportunistic screening of those under the age of 25 in healthcare settings might not be cost-effective. Adams et al’s study is directly relevant to the National Chlamydia Screening Programme in England. They used empirical data from the programme’s pilot studies, and modelled the main screening approach used in the programme in a state-of-the-art mathematical model. The only scenarios that were cost effective required assumptions that the rate of progression of chlamydia to pelvic inflammatory disease was …